SAN ANTONIO — The Cancer Prevention and Research Institute of Texas has awarded nearly $3.4 million to UT Health San Antonio to advance research on hard-to-treat cancers and boost HPV vaccination rates.
Of the funding, $2.4 million will be used to expand core facilities at the university with technology currently unique to San Antonio. This enhancement will enable researchers to tackle drug-resistant cancers.
Dr. Daohong Zhou, director of the Target Discovery Core at the Greehey Children’s Cancer Research Institute, emphasized the ongoing challenges in cancer treatment despite recent progress…